ResMed Inc. (RMD) Dividend History

ResMed Inc. is a healthcare company that specializes in developing, manufacturing, and marketing medical equipment primarily for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, the company is known for its innovative sleep and respiratory care solutions, including devices such as CPAP machines, ventilators, and related accessories. ResMed operates globally, serving both individual patients and healthcare providers.

9001 Spectrum Center Blvd., San Diego, CA, 92123
Phone: (858) 746-2400
Website: https://www.resmed.com

Dividend Yield: 0.79%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
June 12, 2025	$0.53	05/08/2025	05/08/2025
March 20, 2025	$0.53	02/13/2025	02/13/2025
December 12, 2024	$0.53	11/07/2024	11/07/2024
September 19, 2024	$0.53	08/15/2024	08/15/2024
June 13, 2024	$0.48	05/08/2024	05/09/2024
March 14, 2024	$0.48	02/07/2024	02/08/2024
December 14, 2023	$0.48	11/08/2023	11/09/2023
September 21, 2023	$0.48	08/16/2023	08/17/2023
June 15, 2023	$0.44	05/10/2023	05/11/2023
March 16, 2023	$0.44	02/08/2023	02/09/2023
December 15, 2022	$0.44	11/09/2022	11/10/2022
September 22, 2022	$0.44	08/17/2022	08/18/2022
June 16, 2022	$0.42	05/11/2022	05/12/2022
March 17, 2022	$0.42	02/09/2022	02/10/2022
December 16, 2021	$0.42	11/09/2021	11/11/2021
September 23, 2021	$0.42	08/18/2021	08/19/2021
June 17, 2021	$0.39	05/12/2021	05/13/2021
March 18, 2021	$0.39	02/10/2021	02/11/2021
December 17, 2020	$0.39	11/10/2020	11/12/2020
September 24, 2020	$0.39	08/19/2020	08/20/2020
June 18, 2020	$0.39	05/13/2020	05/14/2020
March 19, 2020	$0.39	02/12/2020	02/13/2020
December 12, 2019	$0.39	11/06/2019	11/07/2019
September 19, 2019	$0.39	08/14/2019	08/15/2019
June 13, 2019	$0.37	05/08/2019	05/09/2019
March 14, 2019	$0.37	02/06/2019	02/07/2019
December 13, 2018	$0.37	11/07/2018	11/08/2018
September 20, 2018	$0.37	08/15/2018	08/16/2018
June 14, 2018	$0.35	05/09/2018	05/10/2018
March 15, 2018	$0.35	02/07/2018	02/08/2018
December 14, 2017	$0.35	11/08/2017	11/09/2017
September 21, 2017	$0.35	08/15/2017	08/17/2017
June 15, 2017	$0.33	05/09/2017	05/11/2017
March 16, 2017	$0.33	02/07/2017	02/09/2017
December 15, 2016	$0.33	11/08/2016	11/10/2016
September 22, 2016	$0.33	08/16/2016	08/18/2016
June 16, 2016	$0.30	05/17/2016	05/19/2016
March 17, 2016	$0.30	02/09/2016	02/11/2016
December 17, 2015	$0.30	11/17/2015	11/19/2015
September 17, 2015	$0.30	08/18/2015	08/20/2015
June 18, 2015	$0.28	05/19/2015	05/21/2015
March 19, 2015	$0.28	02/10/2015	02/12/2015
December 18, 2014	$0.28	11/18/2014	11/20/2014
September 18, 2014	$0.28	08/19/2014	08/21/2014
June 17, 2014	$0.25	05/16/2014	05/20/2014
March 19, 2014	$0.25	02/14/2014	02/19/2014
December 18, 2013	$0.25	11/15/2013	11/19/2013
September 17, 2013	$0.25	08/16/2013	08/20/2013
June 18, 2013	$0.17	05/17/2013	05/21/2013
March 19, 2013	$0.17	02/14/2013	02/19/2013
December 18, 2012	$0.17	11/16/2012	11/20/2012
September 28, 2012	$0.17	09/05/2012	09/07/2012

Dividends Summary

ResMed Inc. has issued 52 dividend payments over the past 13 years
The most recent dividend was paid 41 days ago, on June 12, 2025
The first recorded dividend was paid on September 28, 2012
The highest dividend payout was $0.53 per share
The average dividend over this 13 year span is $0.36 per share
ResMed Inc. has increased its dividend payments by 211.76% since 2012

Company News

Sleep Apnea Devices Market is expected to generate a revenue of USD 14.59 Billion by 2031, Globally, at 10.42 % CAGR: Verified Market Research®

The global sleep apnea devices market is projected to grow from $7.08 billion in 2024 to $14.59 billion by 2031, with a 10.42% CAGR, driven by rising sleep disorder prevalence, technological advancements, and improved diagnostic capabilities.

GlobeNewswire Inc.

Featured Companies: PHG
ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

ResMed reported strong Q3 results with double-digit EPS growth and a tariff exemption, leading analysts to boost their price forecasts for the company.

Benzinga
ResMed: Digital Health Drives Q2 Growth

ResMed, a leader in sleep apnea and respiratory care solutions, reported robust fiscal 2025 second-quarter earnings, surpassing analyst expectations. The strong performance was driven by high demand for sleep-related products and growth in digital health solutions.

The Motley Fool
Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics

ResMed reported revenue of $1.22 billion and EPS of $2.08 for Q2 2024, beating analyst estimates. The company saw growth across its various business segments, including devices, masks, and software as a service.

Zacks Investment Research

Page data last updated 07/23/2025 01:33:32 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included

ResMed Inc. (RMD) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies